Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

GE HealthCare (GEHC)

NASDAQ: GEHC · Medical Devices · Chicago, IL

Our rating: Neutral

Call changed from Positive to Neutral at $76.42, moderate conviction, October 29, 2026.

Breaks if: The Neutral call turns Positive if revenue growth sustains above 7% year-over-year or net margin prints above 13% across two consecutive quarterly reports within the next 12 months. It turns Cautious if revenue growth falls below 2% year-over-year or net margin compresses below 8% in any two consecutive quarterly reports within the same window.

Key figures

Market value$36.5B
Revenue, last 12 months$21.6B
Net income, last 12 months$2.2B
Free cash flow, last 12 monthsn/a
Price to earnings16.9×
Free cash flow yieldn/a
Dividend yield0.2%
Operating margin13.3%
Return on equity19.9%
Beta to the S&P 5000.99
Volatility, annualized33.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$5.5B7.2%$1.36$793M
June 30, 2026$5.3B5.8%$1.24$68M
March 31, 2026$5.1B7.4%$0.85$112M
December 31, 2025$5.7B7.1%$1.29n/a
September 30, 2025$5.1B5.8%$0.98$483M
June 30, 2025$5.0B3.5%$1.06$8M
March 31, 2025$4.8B2.7%$1.23$98M
December 31, 2024$5.3B2.2%$1.57n/a

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

11 ledger entries and 24 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.